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ABSTRACT
Background: To test the hypothesis that both daily
activities and sleep quality may be mutually disturbed
in elderly subjects with chronic obstructive pulmonary
disease (COPD) or bronchial asthma (BA) and to
determine factor(s) that relate to deterioration.
Methods: Elderly subjects with chronic airflow obstruc-
tion (group R; n = 60), consisting of COPD and BA,
were compared with subjects without respiratory symp-
toms (group C; n = 53). Both daily activities and sleep
quality were assessed by force–gravity (GF) measure-
ment using an accelerometer.
Results: The night study showed that both total sleep-
ing period and frequency of GF in group R were
increased significantly compared with group C. Subjects
with BA showed fewer movements differing from those
in COPD subjects. The daytime study indicated that the
frequency of GF was greater in group C than in group
R, suggesting reduced daily activities in group R.
Subjects with BA showed more movement than COPD
subjects. Hypercapnia was a significant factor causing
COPD subjects to move more frequently during sleep
and a decrease in peak flow rate was a significant
factor in the reduction of movement during the day in
subjects with BA.
Conclusions: It is assumed that elderly subjects with
COPD or bronchial asthma require a longer sleep
period than subjects without respiratory symptoms
because of the deterioration of sleep quality in the
former group and the sleeping pattern differs between
subjects with COPD and BA. Hypercapnia is consid-
ered a possible factor disturbing sleeping quality in
COPD, whereas decreased peak expiratory flow rate is
a factor reducing daytime activities in subjects with BA.
Key words: bronchial asthma, chronic obstructive
pulmonary disease, daily activities, elderly patients,
sleep quality.
INTRODUCTION
Patients with chronic obstructive pulmonary disease
(COPD) and bronchial asthma (BA) may demonstrate
nocturnal alterations in ventilation and gas exchange
related to the development of bronchospasm or unre-
lated to bronchospasm or to changes in airway resis-
tance.1 Nocturnal hypoxemia and hypoventilation may
occur in subjects with severe COPD alone, but these
changes are usually most pronounced when coexisting
obesity and obstructive sleep apnea are present.2 In such
cases, which are often referred to as overlap syndrome,
treatment that effectively eliminates obstructive sleep
apnea is often sufficient to reduce the consequences of
daytime hypercapnia and right ventricular dysfunction.3
Elderly patients with COPD are prone to occasional sleep
disorders or are at high risk for sleep apnea syndrome.4–6
It has been reported that impaired night-time sleep
quality may increase the risk of sudden death due to fatal
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arrhythmias or severe hypoxemia during sleep.1 However,
most subjects with asthma waken with nocturnal asthma
from time to time and even stable asthma impairs noc-
turnal sleep quality as well as daytime cognitive perfor-
mance.7 During the daytime, compensatory sleep may
occur and, subsequently, a deterioration in the activities
of daily living may occur in subjects with COPD or BA.
We tested the hypothesis that both daily activities and
sleep quality may be mutually affected in elderly subjects
with COPD or BA. If so, it would be useful to identify any
causal factors. To assess small movements of the trunk
during sleep and during the day we used a non-invasive
monitor, namely an accelerometer.
METHODS
Between April 1996 and October 1996, consecutive
patients consulting the outpatient clinic of the Pulmonary
Division of the Tokyo Metropolitan Geriatric Medical
Center (TMGMC), Tokyo, Japan, were screened to deter-
mine their eligibility for inclusion in the study. To be eligi-
ble, patients had to: (i) be over 60 years of age; (ii) be
followed at the outpatient clinic of the Pulmonary Division
of TMGMC; and (iii) have a clinical diagnosis of BA or
COPD. All subjects with one of the above diagnoses were
classified as having chronic airflow obstruction and des-
ignated as group R.
Chronic obstructive pulmonary disease and BA were
diagnosed in accordance with the respective definitions
of the recently published American Thoracic Society.8
Because differentiation of COPD from BA in elderly sub-
jects maybe controversial, special attention was paid 
to smoking history to distinguish COPD and to testing
the bronchodilator response (greater 15% or 200 mL) 
to distinguish BA.9
A control group, elderly subjects with hypertension
receiving regular regimens and without any respiratory
symptoms (group C; n = 53) from whom similar informed
consent was obtained, were compared with group R sub-
jects. Prior to the study, subjects in groups R and C were
selected at random without any criteria other than age,
which was restricted to over 60 years.
Subjects were enrolled after obtaining appropriate
informed consent from the subjects themselves or from
their care givers. The study was approved by the ethics
committee of the Institute.
Spirometry was performed with appropriate attention
to elderly subjects, as described previously.10 Arterial
blood gas was simultaneously measured while breathing
room air in a supine position. Pulmonary function tests
and arterial blood gases were measured for all group R
subjects.
Cognitive function was measured by the Mini-Mental
State Examination (MMSE).11
Activities of daily living (ADL) were measured for basic
ADL (BADL) which mainly reflects the basic or minimum
daily activity (e.g. toilet, eating or bathing) and instrumen-
tal ADL (IADL), which mainly reflects active daily activity
(e.g. shopping or hobby), as described previously.12
The accelerometer (GMS Co., Tokyo, Japan), which is
designed to select the desired threshold of gravity–forces
0.02 g, along with the average gravity–force per minute,
was fit on a belt at the iliac level. As described previ-
ously,13 it is considered unlikely that the accelerometer
would disturb the daily activities of subjects. However,
each subject received careful advice by a trained nurse
that the accelerometer should remain mobile on the body
trunk, but should not touch the bed sheet in the absence
of movement during the night. Measurements were
obtained continuously for 48 h, but only the data from
the second day were used to avoid the effect of the first
day. All records obtained by the accelerometer were
analyzed using a personal computer and appropriate
software (GMS Co.).
The start of ‘sleep’ was defined as the point where con-
tinuous recording data changed from a vertical pattern
(active mode) to a horizontal pattern (resting mode); sim-
ilarly, ‘waking’ was defined as the time of change from a
horizontal pattern to a vertical pattern. Total sleep period
(TSP) was calculated using these points. Unrelated to the
accelerometer recording, each subject was requested to
log his own activity in detail, such as bathing, use of the
toilet and eating, throughout each test day. Based on
the logs and the accelerometer record in combination,
these data were used to determine precisely the times of
sleeping and waking.
The remaining time after subtracting TSP was defined
as daytime.
To identify factors that influence the higher frequency of
GF between group R and group C subjects or between
COPD and subjects with BA, all 23 variables presented 
in Table 1 of pulmonary function and arterial blood gas
were compared by stepwise logistic regression.
Results are expressed as the mean±SEM. We con-
ducted categorical analysis using the Chi-squared test or
Fisher’s exact test. Group means were compared by analy-
sis of variance (ANOVA) followed by multiple comparison
of means by Fisher’s least-significance procedures. All
statistical tests were two-tailed and P < 0.05 was consid-
ered significant. When a significant difference in age or
gender distribution was observed, an adjustment calcula-
tion was made.
RESULTS
The mean age of group R subjects (n = 64) was 76.7 ±
0.9 years (range: 65–88 years), which was higher than
that of group C subjects (34 males and 19 females;
mean age 71.4 ± 1.0 years, range 65–90 years; n = 53;
P < 0.001). Therefore, an age-adjustment calculation
was made to avoid the effect of age difference in com-
parison with group C.
Background data of subjects with COPD and BA in
group R are shown in Table 2. Group R consisted of
COPD (n = 46; 37 males and nine females) and BA 
(n = 18; eight males and 10 females).
There was no significant difference in the distribution of
males and females or in age between groups R and C or
the subgroups of COPD and BA within group R, although
there was a difference in gender distribution, with men
accounting for 80.4% of COPD and 44.4% of subjects
with BA.
Cognitive function data, as shown by MMSE, ADL,
including BADL and IADL, pulmonary function test data
and arterial blood gas values for subjects with COPD and
BA did not differ significantly.
Sleep study
Mean TSP in group R subjects was significantly longer
than that in group C subjects (509.3 ± 11.8 vs 478.9 ±
14.5 min, respectively; P < 0.04).
The mean frequency of 0.02 g during TSP was com-
pared between groups R and C. It was assumed that
sleep quality may differ at the onset or near waking and
the total sleep time may differ from person to person.
Therefore, total sleep time was divided equally into eight
parts for all subjects. The frequencies of 0.02 g per min
was transformed to a log-scale for convenience of 
calculation.
Data on the frequencies of 0.02 g in all but the first
(L1) and last (L8) parts were significantly larger in group R
than in group C (Fig. 1). Because there was a difference
in mean age between the two groups, all data were
adjusted for age and gender ratio between groups R and
C; however, the significance of the difference remained
the same (data not shown).
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Table 1 Parameters and stepwise analysis to detect factors contributing to the increase 0.02 g in chronic airflow obstruction
Parameter
Vital capacity (VC) Resudual volume/total lung capacity (RV/TLC) V˙50 pH
V˙25 PaC O 2
Resudual volume (RV) PaO 2
Tidal volume (TV) HCO3
Functional resudual capacity (FRC) Minute ventilation (MV) O2 saturation
Respiratory rate (RR) Aa-DO2
Total lung capacity (TLC) Functional vital capacity (FVC)
FEV1 Maximal voluntary BMI
ventilation (MVV)
FEV1/FVC
Maximum mid-expiratory flow (MMF)
Peak expiratory flow rate (PF)
FEV1, forced expiratory volume in 1 s; BMI, body mass index.
Table 2 Cognitive function, activities of daily living, pulmonary
function and arterial blood gas data
COPD BA
(n = 43) (n = 17)
MMSE 26.88 ± 0.54 24.88 ± 1.26
BADL 19.72 ± 0.11 19.63 ± 0.38
IADL 21.52 ± 1.02 27.63 ± 0.96
VC 2.30 ± 0.13 2.36 ± 0.17
%VC 84.00 ± 3.77 96.35 ± 4.53
FEV1.0 1.01 ± 0.07 1.25 ± 0.09
FEV1.0/FVC (%) 52.72 ± 2.53 60.06 ± 4.11
FEV1.0% predicted 43.83 ± 4.33 66.02 ± 10.50
PaO 2 75.56 ± 2.06 80.88 ± 1.71
PaC O 2 43.52 ± 1.10 40.28 ± 0.80
MMSE, Mini-Mental State Examination; BADL, basic activities of
daily living; IADL, instrumental activities of daily living; VC, vital
capacity; FEV1.0, forced expiratory volume in 1 s; FVC, functional vital
capacity.
Among patients in group R, there was a trend for 
subjects with BA to show greater frequency than COPD
subjects (Fig. 2) at the initial L1–2 and last parts L7–8,
thus showing a U-shaped pattern; however, this was
inverse at L5, suggesting that patients with BA showed
more fluctuations during sleep than COPD subjects.
To determine the factors that influence the higher 
frequency in group R subjects compared with group C
subjects, all 23 variables (Table 1) were compared for
mean frequency during L1–8 by stepwise regression.
Among all the variables, only the increase in PaCO 2 was
significant (P < 0.02) in COPD subjects but not in sub-
jects with BA.
Daytime study
Hours in the daytime were calculated by subtracting the
TSP from 24 h. Mean counts of 0.02 g for the total daily
hours were calculated and each count over the mean
count per 1 min was calculated and designated as
‘NCV’. The NCV was greater in group C than in group R
(P < 0.05; Fig. 3). When the NCV was compared
between BA and COPD, the former was larger than the
latter (P < 0.02; Fig. 4). The NCV and both forced expi-
ratory volume in 1 s (FEV1.0) and peak expiratory flow rate
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Fig. 1 Comparisons between groups and of chronic airflow
obstruction combined with chronic obstructive pulmonary
disease and bronchial asthma (group R; ——) and control
groups (group C; ------) during sleep. Data on the frequen-
cies of 0.02 g during sleep in all but the first (L1) and last (L8)
parts were significantly larger in the group with chronic airflow
obstruction (group R) than in the non-respiratory control group
(group C). †P < 0.05; *P < 0.01; **P < 0.001.
Fig. 2 Comparisons among groups of chronic obstructive
pulmonary disease (COPD; ––+––) and bronchial asthma (BA; 
(---+--- patients during sleep. Among patients with COPD and
BA, there was a tendency for asthma patients to show a greater
frequency of movement than COPD patients at the initial L1–L2
and last parts L7–8, thus showing a U-shaped pattern during
sleep. However, there was an inverse tendency at L5, suggest-
ing that patients with BA showed a greater frequency of move-
ment at the mid-point of sleep than did COPD patients.
Fig. 3 Comparisons between groups with chronic airflow
obstruction combined with chronic obstructive pulmonary
disease (COPD) and bronchial asthma (BA) and the control
group during the daytime. Rest hours in the daytime was calcu-
lated by subtracting total hours for sleeping time from 24 h for
each patient. Mean counts of 0.02 g for all daytime hours was
calculated and each count exceeding the mean for 1 min was
calculated and designated as ‘NCV’ (see text). The NCV was
greater in the control group without respiratory symptoms than
in the groups with chronic airflow obstruction combined with
COPD and BA (P < 0.05).
were significantly correlated (both P < 0.02). Stepwise
analysis revealed that only the peak expiratory flow rate
contributes significantly to changes in NCV (P < 0.02).
DISCUSSION
The present study first clarified that both daily and noctur-
nal movements were mutually affected in subjects with BA
or COPD and values of peak expiratory flow rate and
hypercapnia were considered factors affected by BA and
COPD, respectively.
Our study design has several limitations that may
have influenced our results. The present study used an
accelerometer to assess both ADL and sleep quality. This
device has the advantage of being small, handy, non-
invasive and inexpensive. It is easy to obtain subject
cooperation because it requires only minimum distur-
bance of the usual life pattern and repeated examina-
tions are possible. An actigraph was obtained from
accelerometer measurements, which has been used to
study insomnia,14 depression15 or nocturnal blood pres-
sure dipping,16 in order to assess sleep quality. It has been
reported that data obtained by the accelerometer are well
correlated with polysomnographic data17,18 and that
the accelerometer provides more objective information
about sleep than do sleep logs.14 Accelerometer data
can also be used to assess daytime activity.19 Although
accelerometers used in previous studies were fitted onto
the wrist, the present study fitted the accelerometer onto a
belt at the iliac level to avoid touching the bed sheet in
the absence of movement during the night. This seemed
more reasonable for detecting trunk movements rather
than wrist movements alone. Using the accelerometer,
three kinds of gravity–force can be measured. Based on a
preliminary study, we choose 0.02 g for analysis because
two other scales of gravity–force were too small to detect
the movements or too large to calculate. The TSP was
divided equally into eight parts, based on an epidemio-
logic study of approximately 5000 Japanese that showed
that the standard sleep period ranges between 7 and 
8 h.20
Despite the precautions described above, the present
study revealed several important findings, which included
the following: (i) elderly subjects with COPD or BA may
require longer sleep periods than control subjects; (ii) the
sleeping pattern differed between subjects with COPD
and BA; and (iii) hypercapnia is a likely factor disturbing
the quality of sleep in COPD subjects, while decreased
peak expiratory flow rate is a likely factor reducing
daytime activities in subjects with BA.
Nocturnal hypoxemia and hypoventilation may occur
in subjects with severe COPD alone, but such changes
are usually most pronounced when coexisting obesity
and obstructive sleep apnea (OSA) are present.2 In such
cases, which are often referred to as overlap syndrome,
the effects of obesity and OSA are usually predominant
and treatment that effectively eliminates OSA is often
sufficient to reduce the consequences of daytime hyper-
capnia and right ventricular dysfunction.3 Daytime hyper-
capnia in COPD subjects was found to determine sleep
quality in the present study. Alterations in nocturnal 
gas exchange, particularly oxygen desaturation, are an
important clinical problem in subjects with COPD. The
present data suggest that subjects with COPD and hyper-
capnia require treatment of sleep-disordered breathing
in COPD, including oxygen therapy and pharmacologic
agents, as well as non-invasive positive pressure ventila-
tion, and it is expected that the improved sleep quality
results in increased daily activities. Sleep deprivation can
result in significant changes in cognitive functioning,
which is occasionally seen in elderly subjects.21 Sleepy
subjects often report difficulty with short-term memory.
Attention may be impaired and subjects may actually
present themselves as having attention deficit disorder.
Sleep deprivation can also result in an alteration of
mental status, which resembles depression or anxiety.
Patients may report poor mood, irritability, low energy,
decreased libido and other signs of psychologic dysfunc-
tion. These symptoms often disappear abruptly when
normal sleep is restored.
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Fig. 4 Comparison of daily movement as assessed by the
accelerometer between patients with chronic obstructive pul-
monary disease (COPD) and bronchial asthma (BA). When
NCV (see text) was compared between BA and COPD patients,
the measurement in the former group was larger than that in
the latter group (P < 0.02).
The present study revealed that mutual effects were
observed in both daily activity and sleep quality in 
subjects with COPD or BA, respectively. Currently, it is
reported that the level of daytime activity is positively cor-
related with sleep efficiency during the subsequent night,
especially for the consistently less-active elderly.19
Recently, Punjabi et al.22 reported that nocturnal hypox-
emia and sleep fragmentation are independent determi-
nants of hypersomnolence in sleep-disordered breathing.
This raises a question of whether nocturnal hypoxemia
during sleep occurred in these subejcts with COPD or BA
in the present study. This issue needs further investigation.
The present data indicated that the frequency of
daytime movements differed between BA and COPD sub-
jects; the movement in the daytime of subjects with BA
was suppressed and this is likely correlated with the
changes in peak expiratory flow rates. It is of interest to
note that subjects with BA showed a greater frequency of
movement during mid-sleep than COPD subjects, sug-
gesting that the sleep of asthma subjects may be dis-
turbed by arousals at the initial or late stage. Reduction 
of the peak expiratory flow rate in asthma subjects 
was found to deteriorate daily activities, which is in
accordance with the present guidelines for treating BA,
although the present observation was based on older
subjects only. Subjects with COPD had fewer IADL and,
similarly, a lower FEV1.0 and lower PaO 2 (Table 2) than
asthma subjects had, although there was no significant
difference between COPD and asthma patients. All these
factors, along with other possible factors, such as muscle
weakness, desaturation during exercise and malnutrition,
may contribute to reduction of daily activities as well as
deterioration of sleep quality in COPD subjects com-
pared with that in asthma subjects. This issue also needs
further investigation.
In conclusion, elderly subjects with COPD or BA may
require a longer sleep time than non-respiratory control
subjects because the quality of sleep in the former group
may be disturbed. However, the sleeping pattern may
differ between subjects with COPD and those with BA.
Hypercapnia was a factor disturbing the sleep quality in
COPD subjects, while reduced peak expiratory flow
rate was a factor disturbing daytime activities in sub-
jects with BA.
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